The Data Standard
In the midst of a global COVID-19 pandemic, a top priority for many pharma and biopharma companies is to get a vaccine developed, produced, and delivered to the public as quickly as possible. Ushering a vaccine through rigorous testing protocols and regulatory approvals is not an easy (or quick) effort, but incorporating advanced data analytics could help accelerate the process. Data analytics has proven effective in speeding vaccine development both by enabling more efficient Design of Experiments (DOE) and by creating rapid-scale production rollout processes. Tomasz Adamusiak, Director of Data Science at Pfizer sits down with TDS to explain what his company, Pfizer, is doing with the vaccine as well as what a designed vaccine is.
Meet The Host
Co-Founder & Board Member of HiQ Labs
Darren Kaplan is 2x Founder and recognized as one of the Top 20 Data Science Influencers in 2020. Darren is the co-creator of The Data Standard, the premier networking user-community for data-science, data engineers, and cybersecurity enthusiasts.
Meet The Guest
Director of Data Science at Pfizer
Tomasz Adamusiak, MD, PhD is a Director of Data Science within the Pfizer Innovation Research (PfIRe) Lab and the Digital Medicine & Translational Imaging group at Pfizer. His team is responsible for developing novel digital endpoints, designing decentralized approaches for clinical trials, and applying AI/machine learning methods to generate novel insights from clinical data.